1. Home
  2. IOVA vs BKU Comparison

IOVA vs BKU Comparison

Compare IOVA & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • BKU
  • Stock Information
  • Founded
  • IOVA 2007
  • BKU 2009
  • Country
  • IOVA United States
  • BKU United States
  • Employees
  • IOVA N/A
  • BKU N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • BKU Savings Institutions
  • Sector
  • IOVA Health Care
  • BKU Finance
  • Exchange
  • IOVA Nasdaq
  • BKU Nasdaq
  • Market Cap
  • IOVA 771.4M
  • BKU 2.6B
  • IPO Year
  • IOVA N/A
  • BKU 2011
  • Fundamental
  • Price
  • IOVA $1.88
  • BKU $37.26
  • Analyst Decision
  • IOVA Buy
  • BKU Hold
  • Analyst Count
  • IOVA 10
  • BKU 11
  • Target Price
  • IOVA $12.22
  • BKU $40.55
  • AVG Volume (30 Days)
  • IOVA 10.5M
  • BKU 837.9K
  • Earning Date
  • IOVA 08-07-2025
  • BKU 07-23-2025
  • Dividend Yield
  • IOVA N/A
  • BKU 3.33%
  • EPS Growth
  • IOVA N/A
  • BKU 38.76
  • EPS
  • IOVA N/A
  • BKU 3.21
  • Revenue
  • IOVA $212,679,000.00
  • BKU $972,198,000.00
  • Revenue This Year
  • IOVA $86.62
  • BKU $13.53
  • Revenue Next Year
  • IOVA $69.95
  • BKU $6.80
  • P/E Ratio
  • IOVA N/A
  • BKU $11.60
  • Revenue Growth
  • IOVA 11070.12
  • BKU 11.13
  • 52 Week Low
  • IOVA $1.64
  • BKU $28.21
  • 52 Week High
  • IOVA $12.51
  • BKU $44.45
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 47.47
  • BKU 61.52
  • Support Level
  • IOVA $1.68
  • BKU $37.25
  • Resistance Level
  • IOVA $2.02
  • BKU $38.13
  • Average True Range (ATR)
  • IOVA 0.11
  • BKU 0.84
  • MACD
  • IOVA 0.03
  • BKU 0.18
  • Stochastic Oscillator
  • IOVA 61.42
  • BKU 78.13

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

Share on Social Networks: